Diastika Biotekindo Tbk. vs Central Proteina Prima Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Central Proteina Prima Tbk. trades at Rp50 (market cap 2.98T, 2.22M 24h volume). The key difference: Central Proteina Prima Tbk. is far larger — about 5.8× Diastika Biotekindo Tbk.'s market cap, and Central Proteina Prima Tbk. is more actively traded (2.22M versus 1.22M). Which is the better fit depends on your goals.
| CHEK | CPRO | |
|---|---|---|
Market Cap | 514.17B | 2.98T |
Volume | 1.22M | 2.22M |
Lot | 12.25K | 22.16K |
Turnover | 155.6M | 110.81M |
Average Price | 127.05 | 50 |
Value | 155.6M | 110.81M |
Indicative Equilibrium Price | 126 | 50 |
Indicative Equilibrium Volume | 503 | 32 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.
Read more on CPRO →